全文获取类型
收费全文 | 603篇 |
免费 | 35篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 226篇 |
儿科学 | 11篇 |
妇产科学 | 19篇 |
基础医学 | 74篇 |
口腔科学 | 4篇 |
临床医学 | 42篇 |
内科学 | 76篇 |
皮肤病学 | 7篇 |
神经病学 | 23篇 |
特种医学 | 11篇 |
外科学 | 61篇 |
综合类 | 5篇 |
预防医学 | 39篇 |
眼科学 | 5篇 |
药学 | 16篇 |
肿瘤学 | 20篇 |
出版年
2022年 | 2篇 |
2021年 | 14篇 |
2020年 | 9篇 |
2019年 | 23篇 |
2018年 | 21篇 |
2017年 | 19篇 |
2016年 | 20篇 |
2015年 | 25篇 |
2014年 | 21篇 |
2013年 | 30篇 |
2012年 | 39篇 |
2011年 | 49篇 |
2010年 | 31篇 |
2009年 | 20篇 |
2008年 | 45篇 |
2007年 | 45篇 |
2006年 | 53篇 |
2005年 | 30篇 |
2004年 | 23篇 |
2003年 | 17篇 |
2002年 | 19篇 |
2001年 | 14篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1998年 | 9篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 5篇 |
1991年 | 4篇 |
1990年 | 1篇 |
1989年 | 9篇 |
1988年 | 2篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1974年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有639条查询结果,搜索用时 15 毫秒
1.
2.
Minoo Lenarz Martin Durisin Hartmut Becker Almuth Brandis Thomas Lenarz 《Skull base》2007,17(2):153-156
We report a case of synchronous olfactory bulb meningioma and undifferentiated carcinoma of the nose and paranasal sinuses that involved and destroyed the anterior skull base and mimicked intracranial invasion by a carcinoma. The heterogeneity of tissue types in the skull base gives rise to a diverse variety of benign and malignant neoplasms which have totally different prognoses. Synchronous development of benign and malignant primary tumors both originating from and involving the skull base at the same location is very rare and may cause confusion for both the skull base surgeon and neuroradiologist. 相似文献
3.
T Lenarz 《Laryngo- rhino- otologie》1989,68(11):634-637
In a prospective randomised clinical study on 80 patients with idiopathic sudden hearing loss the therapeutic value of nimodipine was evaluated. Nimodipine is a 4-5-dihydropyridine calcium antagonist with selective spasmolytic and vasodilatory properties on cerebral vessels. The mean improvement of hearing (250, 500, 1000, 2000, 4000 Hz) amounted to 16.5 +/- 11.3 dB as compared with 18.6 +/- 10.2 dB achieved by standard treatment with hydroxyethyl starch (HAES) and naftidrofuryl. The difference is not significant (p greater than 0.2). These results together with the low rate of side effects indicate nimodipine as a therapeutic alternative in cases of hypertension, cardiac failure and allergic predisposition. The possible role of spontaneous recovery on one side and of specific parameters such as rheologic abnormalities or type of audiogram are discussed. They are important for a more sophisticated therapeutic approach towards sudden hearing loss. 相似文献
4.
Ghannadan M Wimazal F Simonitsch I Sperr WR Mayerhofer M Sillaber C Hauswirth AW Gadner H Chott A Horny HP Lechner K Valent P 《American journal of clinical pathology》2003,119(5):663-671
We studied vascular endothelial growth factor (VEGF) expression in bone marrow sections obtained from 3 healthy donors and 41 patients with acute myeloid leukemia (AML) of various French-American-British (FAB) subtypes by immunohistochemical analysis using an anti-VEGF antibody. In normal bone marrow, the anti-VEGF antibody reacted with myeloid progenitor cells and megakaryocytes but not with erythroid cells or mature granulocytic cells. High levels of VEGF were found in the bone marrow in patients with AML-M1, -M2, -M3, -M4, -M4Eo, and -M5. In these leukemias, the vast majority of myeloblasts (> 90%) expressed VEGF. By contrast, in AML-M0, the percentage of VEGF-positive blasts was lower in most cases (median, 42%), and if at all detectable, these blast cells contained only trace amounts of VEGF. In AML-M3 and -M4Eo, maturing granulocytes failed to express VEGF similar to granulocytes in normal bone marrow. In AML-M6, myeloblasts exhibited VEGF, whereas erythroid cells did not. In AML-M7, blast cells and megakaryocytes were identified as major sources of VEGF. In summary, VEGF expression in the bone marrow is restricted to certain stages of differentiation and maturation of myeloid cells and correlates with the FAB category. 相似文献
5.
Meghna R Adhvaryu Narshimha Reddy Minoo H Parabia 《African journal of traditional, complementary, and alternative medicines》2008,5(4):409-418
The anti-tumor activity and chemopreventive potential of four Ayurvedic herbs viz. Curcuma longa L., Ocimum sanctum L., Tinospora cordifolia (Wild) Miers ex Hook.f & Thomas and Zizyphus mauritiana Lam. were evaluated using Dalton Lymphoma ascites (DLA) tumor model in Swiss Albino mice. The outcome was assessed using survival time, peritoneal ascitic fluid (Tumor volume) and hematological indices as parameters. Animals were divided into five groups (n = 6) viz. one DLA control and four Herb + DLA treated groups. All the four herb + DLA groups were pre-treated with respective herbs for 7 days and hematological indices were measured for entire five groups. On day-8 animals were inoculated with 1×106 DLA cells i.p., and Herb + DLA groups were continued with oral herbal treatment for 21-days. Hematological parameters and tumor volume were assessed to find the effects of herbs. Short term in vitro cytotoxicity was determined by Trypan Blue exclusion method and LDH leakage assay using different concentrations of herbal extracts and 5-FU as a positive control and IC50 for each herbal extract and 5-FU were determined. Oral administration of crude herb increased the survival time and decreased the peritoneal ascitic fluid content significantly. Hb, RBCs and total WBC which were altered by DLA inoculation were restored significantly by all the herbs except O. sanctum. All the four herbs showed in vitro cytotoxic activity against DLA cell-line. Moreover inter group comparison of all the four herbs for anti-tumor activity showed efficacy in the following order- T. cordifolia > Z. mauritiana ≥ C. longa > O. sanctum respectively. 相似文献
6.
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals 总被引:4,自引:0,他引:4
Hauswirth AW Natter S Ghannadan M Majlesi Y Schernthaner GH Sperr WR Bühring HJ Valenta R Valent P 《The Journal of allergy and clinical immunology》2002,110(1):102-109
BACKGROUND: Traditionally, the diagnosis of type I allergies is based on clinical data, skin test results, and laboratory test results with allergen extracts. During the past few years, several attempts have been made to refine diagnostic assays in clinical allergy by introducing recombinant allergens and novel markers of IgE-dependent cell activation. OBJECTIVES: We have identified the ectoenzyme CD203c as a novel basophil antigen that is upregulated on IgE receptor cross-linkage. In this study we applied CD203c and a panel of recombinant allergens to establish a novel basophil test that allows for a reliable quantification of IgE-dependent responses at the effector cell level. METHODS: Patients allergic to birch (Bet v 1, n = 15; Bet v 2, n = 8) and grass (Phl p 1, n = 15; Phl p 2, n = 10; Phl p 5, n = 14) pollen allergens, as well as 10 nonallergic donors, were examined. Basophils were exposed to various concentrations of recombinant allergens for 15 minutes and then examined for expression of CD203c by means of flow cytometry. CD203c upregulation was correlated with the increase in CD63. RESULTS: Exposure to recombinant allergens resulted in a dose-dependent increase in expression of CD203c on peripheral blood basophils in sensitized individuals, whereas no increase was seen in healthy control subjects. The effects of the recombinant allergens on CD203c expression were also time dependent. There was a good correlation between allergen-induced upregulation of CD203c and upregulation of CD63 (R = 0.76). CONCLUSION: Flow cytometric quantitation of CD203c on blood basophils exposed to recombinant allergens is a useful approach to determine the allergic state in sensitized individuals and represents a basis for a sensitive novel allergy test. 相似文献
7.
Krauth MT Majlesi Y Florian S Bohm A Hauswirth AW Ghannadan M Wimazal F Raderer M Wrba F Valent P 《International archives of allergy and immunology》2005,138(2):111-120
BACKGROUND: Mast cells (MC) are important effector cells of allergic and inflammatory reactions in diverse organs. These cells interact with a number of other immune cells and structural cells in the tissues as well as with proinflammatory mediators and cytokines. The various interactions are considered to be mediated through distinct cell surface membrane receptors on MC. METHODS: In the present study, we have established the cell surface membrane phenotype of human gastrointestinal MC (HGMC) using a panel of monoclonal antibodies and indirect immunofluorescence staining techniques. RESULTS: HGMC were found to react with antibodies against CD29, CD33, CD44, CD45, CD47, CD54, CD55, CD58, CD63, CD117, CD147, CD151, CD172a, and CD203c. By contrast, HGMC did not express detectable amounts of CD1, CD2, CD4, CD5, CD14, CD15, CD16, CD22, CD24, CD25, CD26, CD27, CD28, CD31, CD32, CD34, CD35, CD88, or CD116. The alpha-chain of the IL-3 receptor (CD123) was detectable neither in resting HGMC nor in HGMC exposed to stem cell factor and interleukin-4. CONCLUSIONS: HGMC express a unique profile of surface antigens including the receptor for mast cell growth factor, adhesion-related molecules, and activation-linked membrane antigens. 相似文献
8.
G. Reuter F. Bördgen F. Dressler S. Schäfer I. Hemmanouil R. Schönweiler T. Lenarz 《HNO》1998,46(11):932-941
Zusammenfassung
Die Messung otoakustischer Emissionen (OAE) wird für H?rscreeninguntersuchungen von Neugeborenen auf Empfehlung der NIH Consensus
Conference im Jahre 1993 in den USA und Europa eingesetzt. Obwohl diese Messungen gegenüber anderen objektiven Me?verfahren
einfacher durchzuführen sind, erfordert die Bedienung des Systems und die Interpretation der Ergebnisse speziell geschultes
Personal. Ein allgemeines objektives H?rscreening in Deutschland hat sich bisher weder bei Neugeborenen noch bei Risikokindern
durchgesetzt, obwohl es wünschenswert w?re, Kinder mit angeborener Innenohrschwerh?rigkeit (Inzidenz: 1–6 von 1000) m?glichst
früh zu erfassen, zu therapieren und zu rehabilitieren. Der Echosensor bietet die M?glichkeit, TEOAE-Messungen mit kurzer
Me?zeit durchzuführen und automatisiert zu bewerten. Sie k?nnten auch von angelerntem Personal durchgeführt werden. Um die
Ergebnisse des Echosensors mit denen des konventionellen TEOAE-Me?ger?ts ILO88 zu vergleichen, wurden OAE-Messungen an 111
Neugeborenen von audiologisch geschulten Personen durchgeführt. Im Rahmen dieser Pilotstudie wurden Reliabilit?t und Validit?t
der Messungen im Vergleich zum Goldstandard der Hirnstammaudiometrie bestimmt. Es zeigte sich eine sehr hohe übereinstimmung
(Sensitivit?t 100%, Spezifit?t 93,3%) zwischen den Ergebnissen beider Methoden. Somit steht mit dem Echosensor ein OAE-Me?verfahren
zur Verfügung, das eine hohe Sensitivit?t und Spezifit?t aufweist und zu einfach bedienen ist. Dieses Ger?t k?nnte einem fl?chendeckenden
Einsatz des H?rscreenings in Deutschland den Weg ebnen.
Eingegangen am 22. Dezember 1996 Angenommen am 9. Juli 1998 相似文献
9.
Soenke H Bartling Rajiv Gupta Attila Torkos Christian Dullin Grabbe Eckhardt Thomas Lenarz Hartmut Becker Timo St?ver 《Otology & neurotology》2006,27(4):491-498
HYPOTHESIS: Flat-panel based volume computed tomography could improve cochlear implant electrode evaluation in comparison with multislice computed tomography. BACKGROUND: Flat-panel based volume computed tomography offers higher spatial resolution and less metal artifacts than multislice computed tomography. Both characteristics could improve the evaluation of challenging but important questions in cochlear implantation assessment, such as an exact imaging of cochlea, osseous spiral lamina, electrode array position, and single electrode contacts. These questions are not currently fully answered by multislice computed tomography. METHODS: Four isolated temporal bone specimens were scanned in a current multislice computed tomography scanner and in two experimental flat-panel based volume computed tomography scanners before and after cochlea implantation. To compare flat-panel based volume computed tomography and multislice computed tomography, four features were rated according to the following criteria: 1) visibility of the cochlea; 2) visibility of the osseous spiral lamina; 3) discernibility of individual electrode contacts; and 4) the ability to determine the electrode array position relative to scala tympani and scala vestibuli. Layer-by-layer microgrinding pictures were used as the ground truth for verification of imaging findings. RESULTS: Flat-panel based volume computed tomography was superior to multislice computed tomography in all four features rated. The cochlea and facial nerve canal were much better delineated in flat-panel based volume computed tomography. The osseous spiral lamina and single electrode contacts were only visible in flat-panel based volume computed tomography. Assessment of implant position with regard to the cochlear spaces was considerably improved by flat-panel based volume computed tomography. CONCLUSION: Cochlear implantation assessment could be improved by flat-panel based volume computed tomography and, therefore, would be highly beneficial for cochlea implantation research and for clinical evaluation. However, these first results were shown by scanning isolated temporal bone specimens; scanning whole human skull bases might be more challenging. 相似文献
10.
Thomas Lenarz Hubert H Lim Guenter Reuter James F Patrick Minoo Lenarz 《Otology & neurotology》2006,27(6):838-843
The auditory midbrain implant (AMI) is a new central auditory prosthesis designed for penetrating stimulation of the human inferior colliculus. The major group of candidates for the AMI consists of neurofibromatosis type 2 (NF2) patients who develop neural deafness because of growth and/or surgical removal of bilateral acoustic neuromas. Because of the absence of a viable auditory nerve, these patients cannot benefit from cochlear implants. An alternative solution has been the auditory brainstem implant (ABI), which stimulates the cochlear nucleus. However, speech perception performance in NF2 ABI patients has been limited. The fact that the ABI is able to produce high levels of speech perception in nontumor patients (with inaccessible cochleae or posttraumatic damage to the cochlear nerve) suggests that limitations in ABI performance in NF2 patients may be associated with cochlear nucleus damage caused by the tumors or the tumor removal process. Thus, stimulation of the auditory midbrain proximal to the damaged cochlear nucleus may be a better alternative for hearing restoration in NF2 patients. We propose the central nucleus of the inferior colliculus (ICC) as the potential site. A penetrating electrode array aligned along the well-defined tonotopic gradient of the ICC should selectively activate different frequency regions, which is an important elementfor supporting good speech understanding. The goal of this article is to present the ICC as an alternative site for an auditory implant for NF2 patients and to describe the design of the first human prototype AMI. Practical considerations for implementation of the AMI will also be discussed. 相似文献